
Beyond Blood Diagnostics is revolutionizing blood diagnostics by providing a portable, real-time blood analysis platform that delivers lab-quality insights from just a drop of blood in 15 minutes. Their patented technology combines microfluidics and AI to analyze individual blood cells with precision, enabling blood diagnostics outside traditional labs in the field, clinics, and homes. Their flagship product, HypoXcell, targets athletes, clinicians, and public health leaders by offering fast, accessible, and reliable blood biomarker tracking to optimize performance, support personalized care, and aid public health monitoring. The company has strong early traction with multiple patents, partnerships, and clinical trials, positioning it as a differentiated player in sports tech, remote diagnostics, and population health markets.

Beyond Blood Diagnostics is revolutionizing blood diagnostics by providing a portable, real-time blood analysis platform that delivers lab-quality insights from just a drop of blood in 15 minutes. Their patented technology combines microfluidics and AI to analyze individual blood cells with precision, enabling blood diagnostics outside traditional labs in the field, clinics, and homes. Their flagship product, HypoXcell, targets athletes, clinicians, and public health leaders by offering fast, accessible, and reliable blood biomarker tracking to optimize performance, support personalized care, and aid public health monitoring. The company has strong early traction with multiple patents, partnerships, and clinical trials, positioning it as a differentiated player in sports tech, remote diagnostics, and population health markets.